OKYO Pharma Ltd (NASDAQ:OKYO) said it will participate in a fireside chat at the Piper Sandler 2026 Virtual Ophthalmology Symposium on July 9, 2026.
The session will feature CEO Robert J. Dempsey and Chief Medical Officer Flavio Mantelli, MD, PhD, and will be moderated by Biren Amin, managing director of healthcare equity research at Piper Sandler & Co.
OKYO is developing investigational therapies for neuropathic corneal pain and anterior segment eye diseases.